Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial Prof Steve Goodacre, PhD, Judith Cohen, PhD, Mike Bradburn, MSc, Prof Alasdair Gray, MD, Prof Jonathan Benger, MD, Prof Timothy Coats, MD The Lancet Respiratory Medicine Volume 1, Issue 4, Pages 293-300 (June 2013) DOI: 10.1016/S2213-2600(13)70070-5 Copyright © 2013 Elsevier Ltd Terms and Conditions
Figure 1 Study profile *Patients could meet ≥1 exclusion criteria. The Lancet Respiratory Medicine 2013 1, 293-300DOI: (10.1016/S2213-2600(13)70070-5) Copyright © 2013 Elsevier Ltd Terms and Conditions
Figure 2 Length of stay after initial hospital attendance The Lancet Respiratory Medicine 2013 1, 293-300DOI: (10.1016/S2213-2600(13)70070-5) Copyright © 2013 Elsevier Ltd Terms and Conditions